1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
Pediatric Vaccines: Epidemiology Forecast to 2028

Pediatric Vaccines: Epidemiology Forecast to 2028

  • May 2019
  • 40 pages
  • ID: 5781580
  • Format: PDF
  • GlobalData


Table of Contents

Search Inside

Pediatric Vaccines: Epidemiology Forecast to 2028

Pediatric vaccination rates are set to reach nearly 90% in the combined nine major markets (9MM: US, France, Germany, Italy, Spain, UK, Japan, Canada, and India) by 2028; this represents a high compliance in children at or under age two years receiving the routine vaccinations required by each market.

The average pediatric vaccination rates in the combined 9MM are expected to increase from 86.89% in 2018 to 88.67% in 2028. While average pediatric vaccination rates are a function of the routine immunization requirements for each market, and include different vaccines/vaccine combinations, dosing, and age groups, the data show encouraging trends towards improved vaccine uptake on a global scale.

The major drivers behind this increase are Italy’s new law expanding mandatory childhood vaccines from four to 10, as well as the large number of newly adopted vaccines in both Japan and India. In 2018 collectively, European markets had an average vaccination rate of 93%, North American markets followed closely with an average vaccination rate of 83%, and Asian markets had an average vaccination rate of 80%.

While these global rates are promising, there is still room for improvement. Addressing the issue of vaccine hesitancy requires further investigation and analysis into specific social, behavioral, and economic factors that play a role in whether or not an individual gets vaccinated.

In the future, continued efforts should focus on carrying out a targeted, actionable, and effective country-specific approach to overcome vaccine hesitancy, and ultimately increase vaccination rates that show signs of a plateau or decline.

The report “Pediatric Vaccines: Epidemiology Forecast to 2028” provide an overview of the risk factors and global trends of pediatric vaccines in the nine major markets (9MM: US, France, Germany, Italy, Spain, UK, Japan, Canada, and India).

- The Pediatric Vaccines Epidemiology Report and Model provide an overview of the risk factors and global trends of pediatric vaccines in the nine major markets (9MM: US, France, Germany, Italy, Spain, UK, Japan, Canada, and India).
- This report also includes a 10-year epidemiological forecast for the vaccinated pediatric population segmented by vaccine, dosing, and age in these nine markets. Dosing and age groups included within the forecast were dependent on the specific vaccine, routine immunization requirements in each market, and availability of vaccination data. Across markets, dose- and age-specific vaccination rates were obtained for children ranging from age zero years (0-12 months) to age seven years (85-96 months), and covered the following vaccines/vaccine combinations: diphtheria, tetanus, pertussis, diphtheria/tetanus/pertussis (DTaP), inactivated poliovirus vaccine (IPV), oral poliovirus vaccine (OPV), diphtheria/tetanus/IPV (DT-IPV), Haemophilus influenzae Type B (Hib), DTaP/IPV/Hib, Hib/meningitis C, hepatitis A (hep A), hepatitis B (hep B), measles/mumps/rubella (MMR), measles, mumps, rubella, measles/rubella (MR), rotavirus, varicella, and Japanese encephalitis (JE).
- The Pediatric Vaccines epidemiology report and model were written and developed by Masters- and PhD-level epidemiologists.
- The Epidemiology Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 9MM.
- The Epidemiology Model is easy to navigate, interactive, and epidemiology-based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over a 10-year forecast period using reputable sources.

Reasons to buy
The Pediatric Vaccines Epidemiology series will allow you to -

- Develop business strategies by understanding the trends shaping and driving the global pediatric vaccines market.
- Quantify patient populations in the global pediatric vaccines market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for pediatric vaccine therapeutics in each of the markets covered.
- Understand magnitude of the pediatric vaccines population by vaccine, dose, and age.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Tularaemia - Pipeline Review, H1 2020

  • $ 2000
  • May 2020
  • 40 pages

Tularaemia - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Tularaemia – Pipeline Review, H1 2020, provides an overview of the Tularaemia (Infectious ...


Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on